Browse the evidence

PGC-1α regulates mitochondrial quality control mechanisms, including fission, fusion, and mitophagy, which impacts age-related mitochondrial dysfunction and insulin sensitivity.

Focus on exercises that stimulate PGC-1α, such as endurance training, to support mitochondrial quality control, not just volume. This may help maintain metabolic health and insulin sensitivity as you age.

PGC-1α plays an important role in skeletal muscle ROS balance through the regulation of anti-oxidant proteins and proton leak.

Exercise that boosts PGC-1α may help manage oxidative stress by enhancing anti-oxidant defenses and reducing proton leak.

Using fixed, high-threshold end criteria (RER ≥ 1.15 or blood lactate ≥ 8.0 mmol/L) to determine maximal oxygen uptake (VO2max) systematically underestimates the VO2max of older adults and women, leading to their exclusion from fitness assessments.

If you are testing older adults or women, do not use rigid cutoffs like RER ≥ 1.15 or Blood Lactate ≥ 8.0 mmol/L. These numbers are too high for their physiology and will falsely label them as 'not trying hard enough' or exclude them from your data. Use age- and sex-adjusted criteria (e.g., lower lactate thresholds for older adults) or rely on voluntary exhaustion combined with RER ≥ 1.0-1.1 to get an accurate VO2max.

Acute sleep deprivation (64 hours) induces physiologic leukocytosis and increases Natural Killer (NK) cell activity, which parallels neurobehavioral fatigue and is reversed by recovery sleep.

Getting less than 8 hours of sleep for a few days doesn't necessarily 'weaken' your immune system in the way people fear. Instead, your body actively mobilizes immune cells (like NK cells and white blood cells) in response to the stress of being awake. This mobilization tracks with how tired you feel. Prioritizing recovery sleep is essential to normalize these levels, as the immune boost disappears once you recover.

Age-related early morning awakening and reduced sleep consolidation are driven by an internal phase advance of the circadian pacemaker and a reduction in the amplitude of the endogenous circadian component of core body temperature, rather than a shortening of the intrinsic circadian period.

If you are older and waking up very early, it is likely due to a shift in your internal biological timing and a weaker sleep drive, not necessarily a 'broken' or 'fast' clock. You can potentially reinforce a later wake time by exposing yourself to bright light in the early morning, which helps anchor the circadian phase later.

The amplitude of the endogenous circadian component of core body temperature is significantly reduced in older adults compared to young adults, contributing to reduced sleep consolidation.

Older adults often have a weaker internal signal for sleep, reflected in a smaller daily fluctuation in body temperature. This weaker signal makes it harder to stay asleep, especially in the early morning hours.

Sleep homeostatic mechanisms, specifically the increase in EEG slow-wave activity (SWA) following sleep deprivation, remain operative in older adults, although baseline and recovery SWA levels are lower than in young adults.

Older adults still build up sleep pressure (homeostasis) effectively, but the resulting deep sleep (SWA) is less intense than in youth. This contributes to fragmented sleep.

Genetic ablation of the nuclear receptor corepressor RIP140 in mice induces a lean phenotype and resistance to high-fat diet-induced obesity by shifting energy balance from storage to expenditure.

This research highlights that metabolic health is heavily regulated by specific genetic switches (like RIP140) that control whether energy is stored as fat or burned as heat. While you cannot change your genetics, this mechanism suggests that therapies targeting these specific nuclear receptor interactions could help manage obesity and metabolic disorders.

Skeletal muscle-specific overexpression of Carnitine Palmitoyltransferase-1 (CPT1) enhances fatty acid oxidation and ameliorates high-fat diet-induced insulin resistance by reducing intramuscular lipid accumulation and inflammatory signaling.

This research suggests that improving the muscle's capacity to transport fatty acids into mitochondria (via CPT1 activity) can reverse insulin resistance caused by a high-fat diet. This is achieved not by blocking fat entry, but by ensuring it is oxidized, which reduces harmful lipid byproducts like diacylglycerol (DAG) that interfere with insulin signaling. While this was achieved via genetic overexpression in rats, it supports the broader principle that enhancing mitochondrial fatty acid flux may be beneficial for insulin sensitivity in the context of high lipid intake.

Erythropoiesis-stimulating agents (epoetin alfa, epoetin beta, and darbepoetin alfa) effectively improve haematological response and reduce red blood cell transfusion requirements in cancer patients with anaemia, but do not provide a survival advantage and may increase the risk of thrombotic events.

For cancer patients with anaemia, epo drugs effectively raise hemoglobin and reduce the need for blood transfusions, improving quality of life. However, they do not extend life and may increase clotting risks. Treatment decisions should weigh these benefits against the lack of survival advantage and potential side effects, adhering to safety guidelines that limit use in patients with higher baseline hemoglobin levels.

In humans, adipose tissue is the predominant source of serum amyloid A (A-SAA), and elevated A-SAA levels in obesity drive systemic inflammation and insulin resistance through the stimulation of proinflammatory cytokines and increased lipolysis.

This research highlights that obesity is not just about excess fat mass but involves active hormonal signaling from fat cells that drives inflammation and insulin resistance. Specifically, fat cells in obese individuals produce high levels of Serum Amyloid A (A-SAA), which triggers inflammatory responses and increases fat breakdown (lipolysis), contributing to metabolic issues. Weight loss significantly reduces these A-SAA levels, which correlates with improved insulin sensitivity. This suggests that treating obesity involves resolving this specific inflammatory signaling pathway, not just reducing energy storage.

Rosiglitazone treatment reduces serum A-SAA levels and adipose A-SAA secretion in obese individuals independent of changes in body weight or fat mass.

This study shows that the drug rosiglitazone can significantly reduce inflammatory markers (A-SAA) in obese individuals without requiring weight loss. This suggests that some medications target specific inflammatory pathways in fat tissue directly. While this is a specific drug finding, it underscores that metabolic health involves complex hormonal signaling that can be modulated pharmacologically, independent of simple caloric balance.

Fasting sweat glucose levels do not robustly predict fasting blood glucose levels across a population of healthy and diabetic subjects, limiting the use of sweat glucose for universal diabetes diagnostics.

Do not rely on sweat glucose sensors to make immediate medical decisions about insulin dosing or hypoglycemia treatment based on population averages. The correlation between sweat and blood glucose is too weak and variable across individuals. Current technology may support personalized longitudinal tracking, but it is not yet a universal diagnostic tool.

The insulin receptor isoform IR-A, which binds IGF-2 and proinsulin, promotes cell proliferation and is associated with detrimental effects like cancer progression and insulin resistance when overexpressed in adult life, whereas IR-B is primarily responsible for metabolic regulation.

This research highlights that not all insulin signaling is the same. The IR-A isoform, which responds to IGF-2 and proinsulin, drives cell growth and is linked to cancer and insulin resistance when overactive in adults. In contrast, IR-B handles metabolic regulation. Future treatments may need to target specific isoforms to manage diabetes without promoting cancer risk, suggesting that precision medicine approaches are necessary for metabolic health.

Proinsulin acts as a selective ligand for the IR-A isoform, stimulating cell proliferation and migration with an affinity similar to IGF-2, thereby contributing to the mitogenic effects of hyperproinsulinemia.

High levels of proinsulin, often seen in early type 2 diabetes, are not just a byproduct of metabolic dysfunction but actively stimulate cell growth by binding to the IR-A receptor. This mechanism links metabolic disorders to increased cancer risk, suggesting that managing proinsulin levels is crucial for preventing proliferative diseases.

Mitochondrial dysfunction and the subsequent release of mitochondrial DAMPs (such as mtDNA and ROS) drive chronic sterile inflammation (inflammaging), which accelerates aging and age-related pathologies.

Focus on maintaining mitochondrial quality control through regular physical activity and healthy metabolic function rather than relying solely on antioxidant supplements. Mitochondrial health supports immune regulation, which is critical for healthy aging.

A decline in mitophagy with age leads to the accumulation of dysfunctional mitochondria, increased ROS, and functional decline, suggesting that restoring mitophagy could mitigate age-related deficits.

Maintaining mitochondrial health through exercise and metabolic health supports natural mitophagy. This is a key factor in preventing age-related muscle loss and fatigue.

Food frequency questionnaires (FFQs) tend to overestimate carotenoid intake compared to weighed dietary records, potentially by two- to three-fold, due to the long list of food choices and lack of correction factors.

When using Food Frequency Questionnaires (FFQs) to track carotenoid intake, be aware that they tend to overestimate actual consumption by two- to three-fold compared to more precise methods like photographic atlases or weighed records. However, FFQs are still valuable for comparing relative intake between different populations or tracking changes over time, as the qualitative ranking of food sources remains accurate. Do not rely on FFQ data for precise dosing calculations.

Physical activity induces epigenetic modifications, including DNA methylation and histone modifications, which can alter gene expression related to mitochondrial function and brain plasticity, potentially creating an 'epigenetic memory' that affects long-term brain health.

Regular physical activity can change how your genes are expressed, potentially protecting your brain against aging and diseases like Alzheimer's. This happens through epigenetic changes that your body makes in response to exercise.

The 'Obesity Paradox' (lower mortality in obese patients with certain chronic diseases) is largely an artifact of using BMI, which fails to distinguish between high fat mass and high muscle mass, and ignores the inflammatory status of visceral fat.

If you have a chronic condition, do not try to gain weight to 'beat' the odds. Focus on preserving muscle mass through resistance training and adequate protein. The 'paradox' is a measurement error; high muscle is good, high visceral fat is bad.

Dietary calcium and vitamin D are inversely associated with hypertension risk, but calcium and vitamin D supplements do not significantly reduce this risk.

Do not rely on calcium or vitamin D supplements to prevent high blood pressure. Instead, focus on dietary sources, specifically low-fat dairy products, which provide these nutrients in a form associated with reduced hypertension risk.

Intermittent hypoxia, the hallmark of Obstructive Sleep Apnoea/Hypopnoea Syndrome (OSAHS), induces oxidative stress by increasing reactive oxygen species (ROS) production, which leads to endothelial dysfunction, inflammation, and subsequent cardiovascular morbidity.

If you have OSAHS, treating the breathing disorder (e.g., with CPAP) is critical not just for sleep quality but to reduce oxidative stress and lower your risk of heart disease. The repeated dropping of oxygen levels during sleep causes chemical damage to your blood vessels; fixing the breathing stops this damage.

Supplemental intakes of EPA and DHA combined up to 5 g/day do not significantly affect glucose homeostasis in healthy or diabetic subjects.

If you have diabetes or are healthy, taking up to 5g/day of combined EPA/DHA will not negatively affect your blood sugar control. You can take this dose without worrying about glucose homeostasis.

High estrogen levels during the ovulatory phase of the menstrual cycle decrease ligament stiffness by inhibiting lysyl oxidase activity, leading to increased knee laxity and a significantly higher risk of anterior cruciate ligament (ACL) injury.

Female athletes should be aware that their risk of ACL injury increases during the ovulatory phase of their menstrual cycle due to hormonal changes that loosen ligaments. While you cannot change your hormones, you can adjust training loads or focus on neuromuscular control exercises during this high-risk window to mitigate the increased laxity.